The Global Value-Based Healthcare Market is estimated to be valued at US$ 12.18 BN in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2031.

Value-based healthcare models, which prioritize population health and cost control, are becoming more and more necessary as fee-for-service healthcare models become increasingly burdensome for people and healthcare organizations.

Key Takeaways

Key players: Key players operating in the Global Value-Based Healthcare Market Growth include Baker Tilly US, LLP, Change Healthcare, Athena Healthcare, Curation Health, UnitedHealth Group, McKesson Corporation, Deloitte, Siemens Medical Solutions USA, Inc., Signify Health, Inc. (Sentara Healthcare), Humana, and NXGN Management, LLC. These players are focusing on partnerships, acquisitions, and developing advanced software and analytics solutions to support value-based care programs.

Growing demand: There is increasing demand for value-based healthcare models from both public and private payers as a way to curb unsustainable cost increases and improve health outcomes. Governments globally are promoting policies that shift reimbursement strategies from fee-for-service to value-based models.

Global expansion: Leading healthcare IT companies and insurers are expanding their value-based care offerings to international markets. Countries in Asia, Europe, Latin America, and other regions are assessing US-based value-based programs and developing similar initiatives tailored to their populations and systems. Global consulting firms also offer services supporting the design and implementation of value-based programs.
Get more insights on Global Value-Based Healthcare Market

Also read related article on Global Value-Based Healthcare Market